{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:55:59Z","timestamp":1788173759951,"version":"build-2803163510"},"reference-count":123,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Invasive fungal infections represent a major challenge in patients who underwent organ transplantation. Overall, the most common fungal infections in these patients are candidiasis, followed by aspergillosis and cryptococcosis, except in lung transplant recipients, where aspergillosis is most common. Several risk factors have been identified, which increase the likelihood of an invasive fungal infection developing after transplantation. Liver transplant recipients constitute a high-risk category for invasive candidiasis and aspergillosis, and therefore targeted prophylaxis is favored in this patient population. Furthermore, a timely implemented therapy is crucial for achieving optimal outcomes in transplanted patients. In this article, we describe the epidemiology, risk factors, prophylaxis, and treatment strategies of the most common fungal infections in organ transplantation, with a focus on liver transplantation.<\/jats:p>","DOI":"10.3390\/jcm12093238","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T12:10:03Z","timestamp":1682943003000},"page":"3238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Invasive Fungal Infections after Liver Transplantation"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-244X","authenticated-orcid":false,"given":"Thomas","family":"Senoner","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Breitkopf","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Treml","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3662","authenticated-orcid":false,"given":"Sasa","family":"Rajsic","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sharma, S., Saner, F.H., and Bezinover, D. (2022). A brief history of liver transplantation and transplant anesthesia. BMC Anesthesiol., 22.","DOI":"10.1186\/s12871-022-01904-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","article-title":"Long-term survival after liver transplantation in 4000 consecutive patients at a single center","volume":"232","author":"Jain","year":"2000","journal-title":"Ann. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000002650","article-title":"No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades","volume":"269","author":"Rana","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.surg.2018.04.039","article-title":"Early mortality after liver transplantation: Defining the course and the cause","volume":"164","author":"Baganate","year":"2018","journal-title":"Surgery."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamasurg.2017.5040","article-title":"Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model","volume":"153","author":"Agopian","year":"2018","journal-title":"JAMA Surg."},{"key":"ref_7","unstructured":"Waki, K. (2006). UNOS Liver Registry: Ten year survivals. Clin. Transpl., 29\u201339."},{"key":"ref_8","unstructured":"US Department of Health and Human Services (2022). Organ Procurement and Transplant Network National Data, US Department of Health and Human Services."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2666-5247(20)30199-3","article-title":"Fungal infections in transplant recipients: Pros and cons of immunosuppressive and antimicrobial treatment","volume":"2","author":"Papon","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1111\/ctr.12186","article-title":"A critical analysis of early death after adult liver transplants","volume":"27","author":"Rana","year":"2013","journal-title":"Clin. Transpl."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Breitkopf, R., Treml, B., Simmet, K., Bukumiri\u0107, Z., Fodor, M., Senoner, T., and Rajsic, S. (2023). Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041520"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.1840060329","article-title":"Adult liver transplantation: An analysis of the early causes of death in 40 consecutive cases","volume":"6","author":"Martinez","year":"1986","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3062.2008.00315.x","article-title":"Infectious complications in living-donor liver transplant recipients: A 9-year single-center experience","volume":"10","author":"Kim","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3748\/wjg.v20.i20.6211","article-title":"Bacterial infection after liver transplantation","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/lt.21991","article-title":"Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes","volume":"16","author":"Bert","year":"2010","journal-title":"Liver Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4254\/wjh.v3.i4.83","article-title":"Infections in liver transplant recipients","volume":"3","author":"Romero","year":"2011","journal-title":"World J. Hepatol."},{"key":"ref_18","unstructured":"(2023, February 27). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Breitkopf, R., Treml, B., Senoner, T., Bukumiri\u0107, Z., and Rajsic, S. (2023). Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients. J. Fungi, 9.","DOI":"10.3390\/jof9020272"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: Outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin. Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med. Mycol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Scolarici, M., Jorgenson, M., Saddler, C., and Smith, J. (2021). Fungal Infections in Liver Transplant Recipients. J. Fungi, 7.","DOI":"10.3390\/jof7070524"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jiac.2015.11.005","article-title":"Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis","volume":"22","author":"Nagao","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/lt.24032","article-title":"Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases","volume":"21","author":"Barchiesi","year":"2015","journal-title":"Liver Transpl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1086\/421957","article-title":"Antifungal prophylaxis in solid-organ transplant recipients: Considerations for clinical trial design","volume":"39","author":"Singh","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000658-199601000-00010","article-title":"Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients","volume":"223","author":"Kusne","year":"1996","journal-title":"Ann. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","article-title":"Invasive aspergillosis in transplant recipients","volume":"78","author":"Paterson","year":"1999","journal-title":"Medicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/TP.0000000000001356","article-title":"Surgical Site Infections After Liver Transplantation: Emergence of Multidrug-Resistant Bacteria and Implications for Prophylaxis and Treatment Strategies","volume":"100","author":"Viehman","year":"2016","journal-title":"Transplantation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/01.TP.0000065178.93741.72","article-title":"Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: Prospective, multicenter, case-controlled study","volume":"75","author":"Husain","year":"2003","journal-title":"Transplantation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-131-10-199911160-00003","article-title":"Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Winston","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_33","first-page":"38","article-title":"Fungal infections complicating orthotopic liver transplantation","volume":"106","author":"Karchmer","year":"1995","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/00007890-200006270-00016","article-title":"Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome","volume":"69","author":"Rogers","year":"2000","journal-title":"Transplantation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Playford, E.G., Webster, A.C., Craig, J.C., and Sorrell, T.C. (2004). Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst. Rev., CD004291.","DOI":"10.1002\/14651858.CD004291.pub2"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00007890-199501150-00009","article-title":"Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study","volume":"59","author":"Tollemar","year":"1995","journal-title":"Transplantation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/174.3.583","article-title":"Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation","volume":"174","author":"Lumbreras","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1432-2277.2002.tb00176.x","article-title":"Antifungal prophylaxis in liver transplant recipients: A randomized placebo-controlled study","volume":"15","author":"Biancofiore","year":"2002","journal-title":"Transplant. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.TP.0000085653.11565.52","article-title":"Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study","volume":"76","author":"Sharpe","year":"2003","journal-title":"Transplantation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/ajt.12925","article-title":"Antifungal prophylaxis in liver transplantation: A systematic review and network meta-analysis","volume":"14","author":"Evans","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12641","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fmb.12.28","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"7","author":"Shoham","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.transproceed.2014.07.056","article-title":"Fungal Infections After Liver Transplantation: Incidence and Outcome","volume":"46","author":"Sganga","year":"2014","journal-title":"Transpl. Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000486548","article-title":"Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?","volume":"36","author":"Utsumi","year":"2019","journal-title":"Dig. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1378\/chest.124.6.2244","article-title":"Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients","volume":"124","author":"Michalopoulos","year":"2003","journal-title":"Chest"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13693780410001731619","article-title":"Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: Approach to developing practical criteria for systematic use in antifungal prophylaxis trials","volume":"43","author":"Paphitou","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archsurg.136.12.1401","article-title":"Temporal assessment of Candida risk factors in the surgical intensive care unit","volume":"136","author":"McKinnon","year":"2001","journal-title":"Arch. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u2018Candida score\u2019) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Saavedra","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1439-0507.2007.01366.x","article-title":"Risk factors for candidaemia in critically ill patients: A prospective surveillance study","volume":"50","author":"Jurado","year":"2007","journal-title":"Mycoses"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00365540701534509","article-title":"Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome","volume":"40","author":"Klingspor","year":"2008","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/CCM.0b013e31816fc4cd","article-title":"Risk factors for albicans and non-albicans candidemia in the intensive care unit","volume":"36","author":"Chow","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk Factors For Invasive Fungal Infections Complicating Orthotopic Liver Transplantation","volume":"170","author":"Collins","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00029330-200804010-00010","article-title":"Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation","volume":"121","author":"Shi","year":"2008","journal-title":"Chin. Med. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/173.2.446","article-title":"Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients","volume":"173","author":"Badley","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients","volume":"103","author":"George","year":"1997","journal-title":"Am. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transplant."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archsurg.134.6.657","article-title":"Candida infections in critically ill trauma patients: A retrospective case-control study","volume":"134","author":"Borzotta","year":"1999","journal-title":"Arch. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0163-4453(03)00120-8","article-title":"Early diagnosis of candidiasis in non-neutropenic critically ill patients","volume":"48","author":"Marrugat","year":"2004","journal-title":"J. Infect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/lt.20827","article-title":"Association of hepatic iron overload with invasive fungal infection in liver transplant recipients","volume":"12","author":"Alexander","year":"2006","journal-title":"Liver Transpl."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e16179","DOI":"10.1097\/MD.0000000000016179","article-title":"Invasive fungal infection in liver transplant recipients in a prophylactic era: A multicenter retrospective cohort study in Korea","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"ref_67","first-page":"645","article-title":"Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients","volume":"22","author":"Alameer","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures","volume":"18","author":"Verweij","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Krifors, A., Ullberg, M., Castegren, M., Petersson, J., Sparrelid, E., Hammarstr\u00f6m, H., Sj\u00f6lin, J., \u00d6zenci, V., and Blennow, O. (2022). T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study. J. Fungi, 16.","DOI":"10.3390\/jof8010086"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"ofac112","DOI":"10.1093\/ofid\/ofac112","article-title":"Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases","volume":"9","author":"Thompson","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crad.2012.02.018","article-title":"Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation","volume":"67","author":"Lim","year":"2012","journal-title":"Clin. Radiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/cid\/cir861","article-title":"Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies","volume":"54","author":"Stanzani","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ejrad.2016.02.009","article-title":"Can magnetic resonance imaging be an alternative to computed tomography in immunocompromised patients with suspected fungal infections? Feasibility of a speed optimized examination protocol at 3 Tesla","volume":"85","author":"Nagel","year":"2016","journal-title":"Eur. J. Radiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anorl.2011.06.005","article-title":"Clinical features and outcome of sphenoid sinus aspergillosis: A retrospective series of 15 cases","volume":"129","author":"Thery","year":"2012","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Marzolf, G., Sabou, M., Lannes, B., Cotton, F., Meyronet, D., Galanaud, D., Cottier, J.-P., Grand, S., Desal, H., and Kreutz, J. (2016). Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0152475"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1097\/TXD.0000000000000673","article-title":"Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality","volume":"3","author":"Bassetti","year":"2017","journal-title":"Transpl. Direct"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/jac\/dku198","article-title":"In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy","volume":"69","author":"Jacobsen","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/422644","article-title":"Infected bilomas in liver transplant recipients: Clinical features, optimal management, and risk factors for mortality","volume":"39","author":"Safdar","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1378\/chest.08-1339","article-title":"Diagnosis and outcome of early pleural space infection following lung transplantation","volume":"135","author":"Wahidi","year":"2009","journal-title":"Chest"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/myc.12740","article-title":"Candiduria in kidney transplant recipients: Is antifungal therapy useful?","volume":"61","author":"Denis","year":"2018","journal-title":"Mycoses"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/501915","article-title":"The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital","volume":"22","author":"Pegues","year":"2001","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-3062.2009.00463.x","article-title":"Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor","volume":"12","author":"Mueller","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1600-6143.2012.04100.x","article-title":"Donor-Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice","volume":"12","author":"Singh","year":"2012","journal-title":"Am. J. Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/01.tp.0000239188.27153.23","article-title":"Candida albicans arteritis transmitted by conservative liquid after renal transplantation: A report of four cases and review of the literature","volume":"82","author":"Mai","year":"2006","journal-title":"Transplantation"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Bitterman, R., Marinelli, T., and Husain, S. (2021). Strategies for the Prevention of Invasive Fungal Infections after Lung Transplant. J. Fungi, 7.","DOI":"10.3390\/jof7020122"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00007890-200104150-00016","article-title":"Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy","volume":"71","author":"Singh","year":"2001","journal-title":"Transplantation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/45.2.239","article-title":"In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy","volume":"45","author":"Rodero","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","author":"Healey","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3389\/fmicb.2019.01585","article-title":"Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization","volume":"10","author":"Capilla","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijid.2019.07.008","article-title":"G-M.; G\u00f3mez-Coronado, V.J. Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis","volume":"86","author":"Civantos","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mmcr.2017.04.004","article-title":"Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis","volume":"16","author":"Sasso","year":"2017","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MCC.0b013e32833e84d2","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Arendrup","year":"2010","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mib.2019.05.008","article-title":"Global epidemiology of emerging Candida auris","volume":"52","author":"Rhodes","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1469-0691.2008.02099.x","article-title":"A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: Molecular typing of environmental and clinical isolates","volume":"14","author":"Blum","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"103915","DOI":"10.1016\/j.resmic.2021.103915","article-title":"Fungal infections diagnosis\u2014Past, present and future","volume":"173","author":"Santos","year":"2022","journal-title":"Res. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.04445-14","article-title":"Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model","volume":"59","author":"Lepak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","article-title":"CD101: A novel long-acting echinocandin","volume":"18","author":"Zhao","year":"2016","journal-title":"Cell. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1093\/jac\/dky242","article-title":"The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis","volume":"73","author":"Garvey","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","article-title":"The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme","volume":"60","author":"Warrilow","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10096-010-0946-7","article-title":"Mycoviruses: Future therapeutic agents of invasive fungal infections in humans?","volume":"29","author":"Netea","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1093\/jac\/dky302","article-title":"Activity of novel antifungal compound APX001A against a large collection of Candida auris","volume":"73","author":"Berkow","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e00374-19","DOI":"10.1128\/AAC.00374-19","article-title":"The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes","volume":"63","author":"Yamashita","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Kastuhisa","year":"1993","journal-title":"J. Antibiot."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida albicans filamentation for antifungal drug development","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: A reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"dlac074","DOI":"10.1093\/jacamr\/dlac074","article-title":"PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia","volume":"4","author":"Taynton","year":"2022","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: A randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:27:19Z","timestamp":1760124439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":123,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jcm12093238"],"URL":"https:\/\/doi.org\/10.3390\/jcm12093238","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,30]]}}}